Actipulse Neuroscience®

Actipulse Neuroscience® is a neurotechnology company focused on developing non-invasive brain stimulation (NIBS) technologies to treat psychiatric and neurological disorders, particularly Major Depressive Disorder (MDD). The company has created a proprietary home-based brain stimulation device that provides hospital-grade treatment for depression, allowing patients to receive effective therapy outside of traditional clinical settings. This device is currently undergoing FDA pivotal trials for depression and is also being tested in pilot studies for Alzheimer's and Parkinson's diseases. Founded by an international team and supported by Y Combinator, Actipulse Neuroscience operates from Paris and Cambridge, MA. The company specializes in transcranial neuromodulation devices that use high-frequency magnetic pulses to address various mechanisms involved in neurodegenerative and psychiatric disorders. Their technology is designed to be accessible and user-friendly, making advanced brain stimulation therapies more convenient and affordable for patients. Actipulse aims to expand its applications to include broader treatment protocols for neurological and psychiatric conditions, emphasizing patient-centered care and accessibility.